Should we still have the COURAGE to perform elective PCI in stable myocardial ISCHEMIA?
作者信息
Mudawi Telal, Al-Khdair Darar, Al-Anbaei Muath, Ali Asmaa, Amin Ahmed, Besada Dalia, Alenezi Waleed
机构信息
Consultant Interventional Cardiologist Hadi Clinic, Block 8, Jabriya , 46307, Kuwait.
Consultant Interventional Cardiologist Hadi Clinic, Block 8, Jabriya, 46307, Kuwait.
出版信息
Br J Cardiol. 2020 Oct 16;27(4):33. doi: 10.5837/bjc.2020.033. eCollection 2020.
Abstract
摘要
相似文献
1
Should we still have the COURAGE to perform elective PCI in stable myocardial ISCHEMIA?在稳定型心肌缺血患者中，我们是否仍有勇气进行择期经皮冠状动脉介入治疗（PCI）？
Br J Cardiol. 2020 Oct 16;27(4):33. doi: 10.5837/bjc.2020.033. eCollection 2020.
2
Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.COURAGE试验和BARI-2D试验后经皮冠状动脉介入治疗量的趋势：来自超过810万例经皮冠状动脉介入治疗的洞察
Int J Cardiol. 2015 Mar 15;183:6-10. doi: 10.1016/j.ijcard.2015.01.053. Epub 2015 Jan 27.
3
Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.《利用血运重建和积极药物评估的临床结果》（COURAGE）试验发表后，稳定型缺血性心脏病经皮冠状动脉介入治疗的地理差异变化。
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):125-30. doi: 10.1161/CIRCOUTCOMES.113.000282. Epub 2013 Dec 17.
4
Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.BARI 2D和COURAGE试验的临床意义：经皮冠状动脉介入治疗的角色演变
Coron Artery Dis. 2010 Nov;21(7):397-401. doi: 10.1097/MCA.0b013e32833d0134.
5
Recent changes in practice of elective percutaneous coronary intervention for stable angina.稳定型心绞痛择期经皮冠状动脉介入治疗实践的近期变化。
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):300-5. doi: 10.1161/CIRCOUTCOMES.110.957175. Epub 2011 Apr 19.
6
Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease.重新评估经皮冠状动脉介入治疗稳定型缺血性心脏病患者的疗效和价值。
JAMA Intern Med. 2016 Aug 1;176(8):1190-4. doi: 10.1001/jamainternmed.2016.3071.
7
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者的医学治疗模式和强度。
JAMA. 2011 May 11;305(18):1882-9. doi: 10.1001/jama.2011.601.
8
Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.稳定性缺血性心脏病的策略： COURAGE 和 BARI-2D 试验的经验教训。
Curr Atheroscler Rep. 2010 Nov;12(6):423-31. doi: 10.1007/s11883-010-0135-2.
9
COURAGE, ORBITA, and ISCHEMIA: Percutaneous Coronary Intervention for Stable Coronary Artery Disease.COURAGE、ORBITA 和 ISCHEMIA 试验：稳定性冠心病的经皮冠状动脉介入治疗。
Interv Cardiol Clin. 2020 Oct;9(4):469-482. doi: 10.1016/j.iccl.2020.07.003.
10
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.采用或不采用经皮冠状动脉介入治疗的优化药物治疗以减轻缺血负担：来自利用血运重建和强化药物评估的临床结果（COURAGE）试验核子亚研究的结果
Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.
引用本文的文献
1
Systematic Review of Literature Citing the ISCHEMIA Trial.系统综述引用 ISCHEMIA 试验的文献。
Curr Cardiol Rep. 2024 May;26(5):325-329. doi: 10.1007/s11886-024-02031-8. Epub 2024 Mar 16.
本文引用的文献
1
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
2
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.非 ST 段抬高型急性冠状动脉综合征中冠状动脉介入策略的最佳时机：系统评价和荟萃分析。
Ann Intern Med. 2013 Feb 19;158(4):261-70. doi: 10.7326/0003-4819-158-4-201302190-00006.
3
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.急性冠状动脉综合征患者行有创治疗时血运重建延迟的影响：来自 ACUITY（急性血管成形术和紧急介入治疗策略）试验的分析。
J Am Coll Cardiol. 2010 Apr 6;55(14):1416-24. doi: 10.1016/j.jacc.2009.11.063.
4
Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.急性冠状动脉综合征的即时干预与延迟干预：一项随机临床试验。
JAMA. 2009 Sep 2;302(9):947-54. doi: 10.1001/jama.2009.1267.
5
A randomized trial of therapies for type 2 diabetes and coronary artery disease.2型糖尿病与冠状动脉疾病治疗的随机试验
N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7.
6
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes.非ST段抬高型急性冠脉综合征中直接与延迟冠状动脉血管成形术的比较
Heart. 2009 May;95(10):807-12. doi: 10.1136/hrt.2008.154815. Epub 2008 Dec 19.
7
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.不稳定型心绞痛和非ST段抬高型心肌梗死患者中早期侵入性与保守治疗策略的比较：一项荟萃分析
JAMA. 2008 Jul 2;300(1):71-80. doi: 10.1001/jama.300.1.71.
8
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up.丹麦急性心肌梗死纤溶治疗与直接血管成形术多中心随机研究（DANAMI - 2试验）：3年随访结果
Eur Heart J. 2008 May;29(10):1259-66. doi: 10.1093/eurheartj/ehm392. Epub 2007 Oct 23.
9
Optimal medical therapy with or without PCI for stable coronary disease.稳定型冠心病接受或不接受经皮冠状动脉介入治疗的优化药物治疗
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
10
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.药物、血管成形术或手术研究（MASS II）的五年随访：一项针对多支冠状动脉疾病三种治疗策略的随机对照临床试验
Circulation. 2007 Mar 6;115(9):1082-9. doi: 10.1161/CIRCULATIONAHA.106.625475.
Zotero 插件